BLRX Share Price

Open 1.17 Change Price %
High 1.19 1 Day 0.02 1.74
Low 1.15 1 Week 0.05 4.46
Close 1.17 1 Month 0.02 1.74
Volume 346234 1 Year 0.09 8.33
52 Week High 1.42
52 Week Low 0.71
BLRX Important Levels
Resistance 2 1.21
Resistance 1 1.19
Pivot 1.17
Support 1 1.15
Support 2 1.13
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
FTR 1.98 -1.98%
FTR 1.98 -1.98%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.10 100.00%
LOCM 0.09 50.00%
SSH 2.31 32.76%
SSH 2.31 32.76%
SSH 2.31 32.76%
LTRE 2.40 31.87%
HPJ 4.90 30.67%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
ORIG 0.23 -68.49%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
VALV 0.02 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

BioLineRx Ltd. (NASDAQ: BLRX)

BLRX Technical Analysis 3
As on 28th Mar 2017 BLRX Share Price closed @ 1.17 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.98 & Buy for SHORT-TERM with Stoploss of 1.08 we also expect STOCK to react on Following IMPORTANT LEVELS.
BLRX Target for March
1st Target up-side 1.36
2nd Target up-side 1.5
3rd Target up-side 1.65
1st Target down-side 0.94
2nd Target down-side 0.8
3rd Target down-side 0.65
BioLineRx Ltd. ( NASDAQ USA Symbol : BLRX )
Sector : N/AIndustry:N/AFull Time Employees:43Business Summary BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. The company And Other Stocks in Same Sector
BLRX
1.17 0.02 (1.74 %)
LT : Buy
ST : Buy
BLRX Other Details
Segment EQ
Market Capital 52288676.00
Sector N/AIndustry:N/AFull Time Employees:43Business Summary BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. The company
Industry N/AFull Time Employees:43Business Summary BioLineRx Ltd., a clinical stage biopharmaceutical de
Offical website http://www.biolinerx.com
BLRX Address
BLRX
19 Hartum Street
PO Box 45158
Jerusalem, 91450
Israel
Phone: 972 2 548 9100
Fax: 972 2 548 9101
BLRX Latest News
Interactive Technical Analysis Chart BioLineRx Ltd. ( BLRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on BioLineRx Ltd.
BLRX Business Profile
BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates under development consist of BL-1020 that is in Phase II/III clinical trials to improve cognitive function in schizophrenia patients; BL-1040, which is under pivotal CE-Mark registration trial for the prevention of cardiac remodeling following an acute myocardial infarction; BL-5010, which has completed Phase I/II clinical trials for non-surgical removal of skin lesions; BL-1021 that has completed Phase Ia clinical trial for the treatment of neuropathic pain or pain that results from damage to nerve fibers, and BL-7040, a synthetic oligonucleotide, which is in Phase II clinical trial for the treatment of inflammatory bowel disease. The Company also has 11 pre-clinical stage development products for various indications. More from Reuters »